Whitehawk Therapeutics Inc
NASDAQ:WHWKBiotechnology
Healthcare
$3.12 +1.42%
+$0.06 today
- Market cap
- $184.11M
- Beta
- 0.77
- P/E (TTM)
- -2.6
- EPS (TTM)
- -$1.67
52W Low $1.57High $5.50
Volume 0.40M
Average 0.31M
Balance Sheet
Inspect the capital base behind the business.
Assets
$150.83M
FY 2025 · Annual
+114.5% YoYLiabilities
$14.52M
FY 2025 · Annual
-18.6% YoYEquity
$136.31M
FY 2025 · Annual
+159.7% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 148.99M | 39.02M | 62.89M | 28.67M | 37.57M |
| Short-term Investments | 0 | 133.54M | 45.96M | 18.57M | 108.13M |
| Net Receivables | 0 | 1.86M | 5.49M | 5.9M | 0 |
| Inventory | 0 | 1.86M | 6.43M | 5.31M | 0 |
| Other Current Assets | 0 | 0 | 3.83M | 0 | 3.32M |
| Total Current Assets | 151.27M | 180.03M | 124.59M | 61.29M | 149.01M |
| Property, Plant & Equipment (Net) | 614K | 2.03M | 5.97M | 7.63M | 3K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.81M | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 2.21M | 2.18M | 1.87M | 1.4M | 1.81M |
| Total Non-current Assets | 6.64M | 4.21M | 7.84M | 9.03M | 1.82M |
| Total Assets | 157.91M | 184.24M | 132.42M | 70.32M | 150.83M |
| Account Payables | 6.44M | 3.52M | 5.9M | 2.16M | 917K |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.47M | 1.57M | 3.08M | 64K | 3.16M |
| Total Current Liabilities | 15.27M | 18.84M | 26.4M | 17.07M | 14.52M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 5.76M | 5.76M | 0 | 202K | 0 |
| Total Non-current Liabilities | 6.23M | 7.02M | 833K | 767K | 0 |
| Total Liabilities | 21.5M | 25.86M | 27.23M | 17.84M | 14.52M |
| Common Stock | 2K | 2K | 2K | 2K | 4K |
| Retained Earnings | (142.69M) | (203.2M) | (268.96M) | (332.65M) | (353.25M) |
| Accumulated OCI | 0 | (115K) | 27K | 16K | 120K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 136.41M | 158.38M | 105.2M | 52.48M | 136.31M |
| Total Debt | 605K | 1.66M | 1.27M | 833K | 0 |
| Net Debt | (148.38M) | (37.36M) | (61.62M) | (27.84M) | (37.57M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $34.8M |
| Short-term Investments | $88.3M |
| Other Current | $2.5M |
| Total Current Assets | $125.5M |
| PP&E (Net) | $2.0K |
| Other Non-current | $1.7M |
| Total Non-current Assets | $1.7M |
| Total Assets | $127.2M |
Analysis
Selected assets total $127.2M for Latest. The largest visible component is Short-term Investments at $88.3M, about 69.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| DEFA14A | DEFA14A filing | Apr 28, 2026 | |
| ARS | ARS filing | Apr 28, 2026 |
How much cash does WHWK have?
Whitehawk Therapeutics Inc (WHWK) reported $37.57M in cash and equivalents in fiscal 2025.
How much debt does WHWK carry?
Whitehawk Therapeutics Inc (WHWK) reported $0.00 of total debt, with net debt of -$37.57M.
Continue the stock analysis
Jump to another research area for this company.